Cabardo, Skyler Finn P.

HRN: 28-53-95  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2026
CEFTAZIDIME 1GM (VIAL)
02/27/2026
03/06/2026
IV
110mg
Q8h
T/C Neonatal Pneumonia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines